Cargando…

Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism

Activating transcription factor 3 (ATF3) is known to have an anti-inflammatory function, yet the role of hepatic ATF3 in lipoprotein metabolism or atherosclerosis remains unknown. Here we show that over-expression of human ATF3 in hepatocytes reduces the development of atherosclerosis in Western die...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yanyong, Li, Yuanyuan, Jadhav, Kavita, Pan, Xiaoli, Zhu, Yingdong, Hu, Shuwei, Chen, Shaoru, Chen, Liuying, Tang, Yong, Wang, Helen H., Yang, Ling, Wang, David Q.-H., Yin, Liya, Zhang, Yanqiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856821/ https://www.ncbi.nlm.nih.gov/pubmed/33462514 http://dx.doi.org/10.1038/s42255-020-00331-1

Ejemplares similares

Retinoic Acid Receptor Alpha (RARα) in Macrophages Protects from Diet-Induced Atherosclerosis in Mice
por: Cassim Bawa, Fathima N., et al.
Publicado: (2022)

Lipocalin‐2 Protects Against Diet‐Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes
por: Xu, Yanyong, et al.
Publicado: (2019)

Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis
por: Zhu, Yingdong, et al.
Publicado: (2023)

Hepatocyte‐Specific Expression of Human Carboxylesterase 1 Attenuates Diet‐Induced Steatohepatitis and Hyperlipidemia in Mice
por: Xu, Yanyong, et al.
Publicado: (2020)

Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease
por: Xu, Yanyong, et al.
Publicado: (2021)

Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
por: Jadhav, Kavita, et al.
Publicado: (2018)

Hepatic retinoic acid receptor alpha mediates all‐trans retinoic acid's effect on diet‐induced hepatosteatosis
por: Cassim Bawa, Fathima N., et al.
Publicado: (2022)

Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury
por: Xu, Jiesi, et al.
Publicado: (2016)

Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr(−/−) mice
por: Xu, Jiesi, et al.
Publicado: (2017)

HDL, Atherosclerosis, and Emerging Therapies
por: Hafiane, Anouar, et al.
Publicado: (2013)

Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
por: Pan, Xiaoli, et al.
Publicado: (2022)

Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress
por: Chen, Huey-Ling, et al.
Publicado: (2012)

Hepatocyte ABCA1 deficiency is associated with reduced HDL sphingolipids
por: Othman, Alaa, et al.
Publicado: (2023)

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2021)

Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation
por: Rein, Philipp, et al.
Publicado: (2010)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
por: Valanti, Eftaxia-Konstantina, et al.
Publicado: (2018)

Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
por: Morin, Emily E., et al.
Publicado: (2020)

HDL signaling and protection against coronary artery atherosclerosis in mice
por: Trigatti, Bernardo L, et al.
Publicado: (2016)

ATF3 and its emerging role in atherosclerosis: a narrative review
por: Wu, Jingyi, et al.
Publicado: (2022)

P2Y13 Receptor Regulates HDL Metabolism and Atherosclerosis In Vivo
por: Goffinet, Marine, et al.
Publicado: (2014)

Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults
por: Kelesidis, Theodoros, et al.
Publicado: (2013)

The LDL-HDL Profile Determines the Risk of Atherosclerosis: A Mathematical Model
por: Hao, Wenrui, et al.
Publicado: (2014)

HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis
por: Borja, Mark S., et al.
Publicado: (2013)

TG/HDL Ratio: A marker for insulin resistance and atherosclerosis in prediabetics or not?
por: Chauhan, Ajay, et al.
Publicado: (2021)

Triglyceride/HDL-Cholesterol Ratio as an Index of Intracranial Atherosclerosis in Nonstroke Individuals
por: Woo, Min-Hee, et al.
Publicado: (2021)

ATF4 deficiency protects hepatocytes from oxidative stress via inhibiting CYP2E1 expression
por: Wang, Chunxia, et al.
Publicado: (2014)

Cellular mechanism of bile acid-accelerated hepatocyte polarity
por: Fu, Dong, et al.
Publicado: (2011)

HDL Size is More Accurate than HDL Cholesterol to Predict Carotid Subclinical Atherosclerosis in Individuals Classified as Low Cardiovascular Risk
por: Parra, Eliane Soler, et al.
Publicado: (2014)

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
por: Srivastava, Neelam, et al.
Publicado: (2018)

HDL functionality is dependent on hepatocyte stress defense factors Nrf1 and Nrf2
por: Trites, Michael J., et al.
Publicado: (2023)

Apical membrane rupture and backward bile flooding in acetaminophen-induced hepatocyte necrosis
por: Li, F-C, et al.
Publicado: (2011)

Activating transcription factor 3, glucolipid metabolism, and metabolic diseases
por: Hu, Shuwei, et al.
Publicado: (2022)

Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice
por: Cao, Jia, et al.
Publicado: (2018)

Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice
por: Ishikawa, Kazunobu, et al.
Publicado: (2012)

Simultaneous Noninvasive Detection and Therapy of Atherosclerosis Using HDL Coated Gold Nanorods
por: Ankri, Rinat, et al.
Publicado: (2022)

Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes
por: Tsujita, Maki, et al.
Publicado: (2017)

Levels of Cholesterol in Small LDL Particles Predict Atherosclerosis Progression and Incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)
por: Williams, Paul T., et al.
Publicado: (2013)

ATF linac commissioning
por: Hayano, H
Publicado: (1996)

Bile Microinfarcts in Cholestasis Are Initiated by Rupture of the Apical Hepatocyte Membrane and Cause Shunting of Bile to Sinusoidal Blood
por: Ghallab, Ahmed, et al.
Publicado: (2018)

Bile Acids Reduce Endocytosis of High-Density Lipoprotein (HDL) in HepG2 Cells
por: Röhrl, Clemens, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e1rsvqc0vsq7eaia75sjtbgj1e